Daily comfort, not transformation promises.
We focus on steady use and honest expectations.
A drug-free approach to peripheral nerve discomfort, developed with specialist clinicians, built for daily home use at 9 p.m. on a Thursday — and the third month in a row.
Nervexus exists for people who have tried the usual options: compression socks, TENS, medication, waiting, hoping, adjusting. We do not promise transformation. We build a serious daily device for the kind of discomfort that becomes quietly normalised.
One product. One price. No countdowns, no fabricated reviews, no miracle language. Just a careful attempt to bring three established mechanisms into a device that fits ordinary life.
Triple Therapy in a single, deliberate device. Twenty minutes. Mains-powered. No drugs, no electrodes, no app.
Thermal support, pulsed compression, and mechanical stimulation in sequence.
Designed for the end of the day, in a chair, in a real living room.
Specialist podiatrists informed the design and the boundaries of the claims.
We focus on steady use and honest expectations.
Clinical mechanisms inform the design; marketing does not write the science.
Made to sit in a living room, not in a sales letter.
Units in the first UK Founding Members cohort.
Structured intake window at 4, 8, and 12 weeks.
First quarterly report scheduled. Pending real cohort outcomes.
Placeholder excerpts until real Founding Member reports are collected.
“The evenings feel less restricted. It is modest, but it is real enough for me to keep using it.”
“I bought it with low expectations. The compression is the part I notice most.”
“I like that it does not pretend to be a cure. It is a useful twenty minutes.”
“My doctor told me to keep all treatments in context. This feels like one careful part of that.”
The first 500 units are not a hype mechanism. They are a learning structure. We would rather learn carefully from hundreds than guess loudly for twenty thousand.
About the Founding Members programme →